Apolipoprotein D modulates amyloid pathology in APP/PS1 Alzheimer's disease mice

Neurobiology of Aging

Volumn 36, Issue 5, 2015, Pages 1820-1833

  Li, Hongyun ^a   Ruberu, Kalani ^a   Muñoz, Sonia Sanz ^a   Jenner, Andrew M ^a   Spiro, Adena ^a   Zhao, Hua ^a   Rassart, Eric ^b   Sanchez, Diego ^c   Ganfornina, Maria D ^c   Karl, Tim ^d,e,f   Garner, Brett ^a  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^c UNIVERSITY OF VALLADOLID   (Spain)

^d NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f Schizophrenia Research Institute   (Australia)

Author keywords

Alzheimer's disease; Amyloid pathology; Amyloid ; Apolipoprotein D; Neurodegeneration

Indexed keywords

4 HYDROXYNONENAL; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN D; APOLIPOPROTEIN E; BETA SECRETASE 1; ISOPROSTANE DERIVATIVE; NEU DIFFERENTIATION FACTOR; AMYLOID PRECURSOR PROTEIN; ASPARTIC PROTEINASE; BACE1 PROTEIN, MOUSE; SECRETASE;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA SHEET; BRAIN CORTEX; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; HIPPOCAMPAL CA3 REGION; LIPID PEROXIDATION; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN DEPLETION; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; DISEASE MODEL; GENETICS; HIPPOCAMPUS; METABOLISM; PATHOLOGY; PROTEIN DEGRADATION; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; APOLIPOPROTEINS D; ASPARTIC ACID ENDOPEPTIDASES; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; MICE, TRANSGENIC; NEUREGULIN-1; PLAQUE, AMYLOID; PROTEOLYSIS;

EID: 84928714878     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2015.02.010     Document Type: Article

References (69)

1. Abbott S.K., Jenner A.M., Mitchell T.W., Brown S.H., Halliday G.M., Garner B. An improved high-throughput lipid extraction method for the analysis of human brain lipids. Lipids 2013, 48:307-318.
2. Abdul H.M., Sultana R., St Clair D.K., Markesbery W.R., Butterfield D.A. Oxidative damage in brain from human mutant APP/PS-1 double knock-in mice as a function of age. Free Radic. Biol. Med. 2008, 45:1420-1425.
3. Adibhatla R.M., Hatcher J.F. Secretory phospholipase A2 IIA is up-regulated by TNF-alpha and IL-1alpha/beta after transient focal cerebral ischemia in rat. Brain Res. 2007, 1134:199-205.
4. Bajo-Graneras R., Ganfornina M.D., Martin-Tejedor E., Sanchez D. Apolipoprotein D mediates autocrine protection of astrocytes and controls their reactivity level, contributing to the functional maintenance of paraquat-challenged dopaminergic systems. Glia 2011, 59:1551-1566.
5. Bajo-Graneras R., Sanchez D., Gutierrez G., Gonzalez C., Do Carmo S., Rassart E., Ganfornina M.D. Apolipoprotein D alters the early transcriptional response to oxidative stress in the adult cerebellum. J.Neurochem. 2011, 117:949-960.
6. Bhatia S., Jenner A.M., Li H., Ruberu K., Spiro A.S., Shepherd C.E., Kril J.J., Kain N., Don A., Garner B. Increased apolipoprotein D dimer formation in Alzheimer's disease hippocampus is associated with lipid conjugated diene levels. J.Alzheimers Dis. 2013, 35:475-486.
7. Bhatia S., Knoch B., Wong J., Kim W.S., Else P.L., Oakley A.J., Garner B. Selective reduction of hydroperoxyeicosatetraenoic acids to their hydroxy derivatives by apolipoprotein-D: Implications for lipid antioxidant activity and Alzheimer's disease. Biochem. J. 2012, 442:713-721.
8. Borchelt D.R., Davis J., Fischer M., Lee M.K., Slunt H.H., Ratovitsky T., Regard J., Copeland N.G., Jenkins N.A., Sisodia S.S., Price D.L. Avector for expressing foreign genes in the brains and hearts of transgenic mice. Genet. Anal. 1996, 13:159-163.
9. Chami L., Checler F. BACE1 is at the crossroad of a toxic vicious cycle involving cellular stress and beta-amyloid production in Alzheimer's disease. Mol. Neurodegener. 2012, 7:52.
10. Chen Y., Jia L., Wei C., Wang F., Lv H., Jia J. Association between polymorphisms in the apolipoprotein D gene and sporadic Alzheimer's disease. Brain Res. 2008, 1233:196-202.
11. Cheng D., Low J.K., Logge W., Garner B., Karl T. Novel behavioural characteristics of female APP/PS1DeltaE9 double transgenic mice. Behav. Brain Res. 2013, 260C:111-118.
12. Cristiano F., de Haan J.B., Iannello R.C., Kola I. Changes in the levels of enzymes which modulate the antioxidant balance occur during aging and correlate with cellular damage. Mech. Ageing Dev. 1995, 80:93-105.
13. Dassati S., Waldner A., Schweigreiter R. Apolipoprotein D takes center stage in the stress response of the aging and degenerative brain. Neurobiol. Aging 2014, 35:1632-1642.
14. Desai P.P., Hendrie H.C., Evans R.M., Murrell J.R., DeKosky S.T., Kamboh M.I. Genetic variation in apolipoprotein D affects the risk of Alzheimer disease in African-Americans. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2003, 116B:98-101.
15. Desai P.P., Ikonomovic M.D., Abrahamson E.E., Hamilton R.L., Isanski B.A., Hope C.E., Klunk W.E., DeKosky S.T., Kamboh M.I. Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex. Neurobiol. Dis. 2005, 20:574-582.
16. De Strooper B., Vassar R., Golde T. The secretases: enzymes with therapeutic potential in Alzheimer disease. Nat. Rev. Neurol. 2010, 6:99-107.
17. Dilley W.G., Haagensen D.E., Cox C.E., Wells S.A. Immunologic and steroid binding properties of the GCDFP-24 protein isolated from human breast gross cystic disease fluid. Breast Cancer Res. Treat 1990, 16:253-260.
18. Do Carmo S., Fournier D., Mounier C., Rassart E. Human apolipoprotein D overexpression in transgenic mice induces insulin resistance and alters lipid metabolism. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E802-E811.
19. Do Carmo S., Jacomy H., Talbot P.J., Rassart E. Neuroprotective effect of apolipoprotein D against human coronavirus OC43-induced encephalitis in mice. J.Neurosci. 2008, 28:10330-10338.
20. Do Carmo S., Levros L.C., Rassart E. Modulation of apolipoprotein D expression and translocation under specific stress conditions. Biochim. Biophys. Acta 2007, 1773:954-969.
21. Droge W., Schipper H.M. Oxidative stress and aberrant signaling in aging and cognitive decline. Aging Cell 2007, 6:361-370.
22. Eichinger A., Nasreen A., Kim H.J., Skerra A. Structural insight into the dual ligand specificity and mode of high density lipoprotein association of apolipoprotein D. J.Biol. Chem. 2007, 282:31068-31075.
23. Elliott D.A., Weickert C.S., Garner B. Apolipoproteins in the brain - implications for neurological and psychiatric disorders. Clin. Lipidol. 2010, 5:555-573.
24. Fleck D., Garratt A.N., Haass C., Willem M. BACE1 dependent neuregulin processing: review. Curr. Alzheimer Res. 2012, 9:178-183.
25. Fleck D., van Bebber F., Colombo A., Galante C., Schwenk B.M., Rabe L., Hampel H., Novak B., Kremmer E., Tahirovic S., Edbauer D., Lichtenthaler S.F., Schmid B., Willem M., Haass C. Dual cleavage of neuregulin 1 type III by BACE1 and ADAM17 liberates its EGF-like domain and allows paracrine signaling. J.Neurosci. 2013, 33:7856-7869.
26. Franklin K.B.J., Paxinos G. The Mouse Brain in Stereotaxic Coordinates 2007, Academic Press, New York, NY, USA. Third ed.
27. Ganfornina M.D., Do Carmo S., Lora J.M., Torres-Schumann S., Vogel M., Allhorn M., González C., Bastiani M.J., Rassart E., Sanchez D. Apolipoprotein D is involved in the mechanisms regulating protection from oxidative stress. Aging Cell 2008, 7:506-515.
28. Garcia-Alloza M., Robbins E.M., Zhang-Nunes S.X., Purcell S.M., Betensky R.A., Raju S., Prada C., Greenberg S.M., Bacskai B.J., Frosch M.P. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Neurobiol. Dis. 2006, 24:516-524.
29. Ghosal K., Vogt D.L., Liang M., Shen Y., Lamb B.T., Pimplikar S.W. Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:18367-18372.
30. Gotz J., Ittner L.M. Animal models of Alzheimer's disease and frontotemporal dementia. Nat. Rev. Neurosci. 2008, 9:532-544.
31. Helisalmi S., Hiltunen M., Vepsalainen S., Iivonen S., Corder E.H., Lehtovirta M., Mannermaa A., Koivisto A.M., Soininen H. Genetic variation in apolipoprotein D and Alzheimer's disease. J.Neurol. 2004, 251:951-957.
32. Higgins G.A., Jacobsen H. Transgenic mouse models of Alzheimer's disease: phenotype and application. Behav. Pharmacol. 2003, 14:419-438.
33. Hu X., Hicks C.W., He W., Wong P., Macklin W.B., Trapp B.D., Yan R. Bace1 modulates myelination in the central and peripheral nervous system. Nat. Neurosci. 2006, 9:1520-1525.
34. Jankowsky J.L., Fadale D.J., Anderson J., Xu G.M., Gonzales V., Jenkins N.A., Copeland N.G., Lee M.K., Younkin L.H., Wagner S.L., Younkin S.G., Borchelt D.R. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide invivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet. 2004, 13:159-170.
35. Kalman J., McConathy W., Araoz C., Kasa P., Lacko A.G. Apolipoprotein D in the aging brain and in Alzheimer's dementia. Neurol. Res. 2000, 22:330-336.
36. Kang J., Lemaire H.G., Unterbeck A., Salbaum J.M., Masters C.L., Grzeschik K.H., Multhaup G., Beyreuther K., Muller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987, 325:733-736.
37. Kim W.S., Bhatia S., Elliott D.A., Agholme L., Kagedal K., McCann H., Halliday G.M., Barnham K.J., Garner B. Increased ATP-binding cassette transporter A1 expression in Alzheimer's disease hippocampal neurons. J.Alzheimers Dis. 2010, 21:193-205.
38. Kim W.S., Li H., Ruberu K., Chan S., Elliott D.A., Low J.K., Cheng D., Karl T., Garner B. Deletion of Abca7 increases cerebral amyloid-beta accumulation in the J20 mouse model of Alzheimer's disease. J.Neurosci. 2013, 33:4387-4394.
39. Kim W.S., Wong J., Weickert C.S., Webster M.J., Bahn S., Garner B. Apolipoprotein-D expression is increased during development and maturation of the human prefrontal cortex. J.Neurochem. 2009, 109:1053-1066.
40. Lagares A., Li H.Y., Zhou X.F., Avendano C. Primary sensory neuron addition in the adult rat trigeminal ganglion: evidence for neural crest glio-neuronal precursor maturation. J.Neurosci. 2007, 27:7939-7953.
41. Lea O.A. Binding properties of progesterone-binding Cyst protein, PBCP. Steroids 1988, 52:337-338.
42. Li H.Y., Say E.H., Zhou X.F. Isolation and characterization of neural crest progenitors from adult dorsal root ganglia. Stem cells 2007, 25:2053-2065.
43. Markesbery W.R., Carney J.M. Oxidative alterations in Alzheimer's disease. Brain Pathol. 1999, 9:133-146.
44. Montine T.J., Quinn J., Kaye J., Morrow J.D. F(2)-isoprostanes as biomarkers of late-onset Alzheimer's disease. J.Mol. Neurosci. 2007, 33:114-119.
45. Morais Cabral J.H., Atkins G.L., Sanchez L.M., Lopez-Boado Y.S., Lopez-Otin C., Sawyer L. Arachidonic acid binds to apolipoprotein D: implications for the protein's function. FEBS Lett. 1995, 366:53-56.
46. Muffat J., Walker D.W., Benzer S. Human ApoD, an apolipoprotein up-regulated in neurodegenerative diseases, extends lifespan and increases stress resistance in Drosophila. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:7088-7093.
47. Oakley A.J., Bhatia S., Ecroyd H., Garner B. Molecular dynamics analysis of apolipoprotein-D-lipid hydroperoxide interactions: mechanism for selective oxidation of Met-93. PLoS One 2012, 7:e34057.
48. Paola D., Domenicotti C., Nitti M., Vitali A., Borghi R., Cottalasso D., Zaccheo D., Odetti P., Strocchi P., Marinari U.M., Tabaton M., Pronzato M.A. Oxidative stress induces increase in intracellular amyloid beta-protein production and selective activation of betaI and betaII PKCs in NT2 cells. Biochem. Biophys. Res. Commun. 2000, 268:642-646.
49. Pearlman W.H., Gueriguian J.L., Sawyer M.E. Aspecific progesterone-binding component of human breast cyst fluid. J.Biol. Chem. 1973, 248:5736-5741.
50. Phillis J.W., Horrocks L.A., Farooqui A.A. Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders. Brain Res. Rev. 2006, 52:201-243.
51. Rassart E., Bedirian A., Do Carmo S., Guinard O., Sirois J., Terrisse L., Milne R. Apolipoprotein D. Biochim. Biophys. Acta 2000, 1482:185-198.
52. Ruiz M., Sanchez D., Correnti C., Strong R.K., Ganfornina M.D. Lipid-binding properties of human ApoD and Lazarillo-related lipocalins: functional implications for cell differentiation. FEBS J. 2013, 280:3928-3943.
53. Sanchez D., Lopez-Arias B., Torroja L., Canal I., Wang X., Bastiani M.J., Ganfornina M.D. Loss of glial lazarillo, a homolog of apolipoprotein D, reduces lifespan and stress resistance in Drosophila. Curr. Biol. 2006, 16:680-686.
54. Sanchez-Mejia R.O., Mucke L. Phospholipase A2 and arachidonic acid in Alzheimer's disease. Biochim. Biophys. Acta 2010, 1801:784-790.
55. Sastre M., Dewachter I., Landreth G.E., Willson T.M., Klockgether T., van Leuven F., Heneka M.T. Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase. J.Neurosci. 2003, 23:9796-9804.
56. Sastre M., Walter J., Gentleman S.M. Interactions between APP secretases and inflammatory mediators. J.Neuroinflammation 2008, 5:25.
57. Sayre L.M., Zelasko D.A., Harris P.L., Perry G., Salomon R.G., Smith M.A. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J.Neurochem. 1997, 68:2092-2097.
58. Schuessel K., Schafer S., Bayer T.A., Czech C., Pradier L., Muller-Spahn F., Muller W.E., Eckert A. Impaired Cu/Zn-SOD activity contributes to increased oxidative damage in APP transgenic mice. Neurobiol. Dis. 2005, 18:89-99.
59. Tamagno E., Parola M., Bardini P., Piccini A., Borghi R., Guglielmotto M., Santoro G., Davit A., Danni O., Smith M.A., Perry G., Tabaton M. Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways. J.Neurochem. 2005, 92:628-636.
60. Terrisse L., Poirier J., Bertrand P., Merched A., Visvikis S., Siest G., Milne R., Rassart E. Increased levels of apolipoprotein D in cerebrospinal fluid and hippocampus of Alzheimer's patients. J.Neurochem. 1998, 71:1643-1650.
61. Terrisse L., Seguin D., Bertrand P., Poirier J., Milne R., Rassart E. Modulation of apolipoprotein D and apolipoprotein E expression in rat hippocampus after entorhinal cortex lesion. Brain Res. Mol. Brain Res. 1999, 70:26-35.
62. Thomas E.A., Laws S.M., Sutcliffe J.G., Harper C., Dean B., McClean C., Masters C., Lautenschlager N., Gandy S.E., Martins R.N. Apolipoprotein D levels are elevated in prefrontal cortex of subjects with Alzheimer's disease: no relation to apolipoprotein E expression or genotype. Biol. Psychiatry 2003, 54:136-141.
63. Thomas E.A., Sautkulis L.N., Criado J.R., Games D., Sutcliffe J.G. Apolipoprotein D mRNA expression is elevated in PDAPP transgenic mice. J.Neurochem. 2001, 79:1059-1064.
64. Vogt M., Skerra A. Bacterially produced apolipoprotein D binds progesterone and arachidonic acid, but not bilirubin or E-3M2H. J.Mol. Recognit 2001, 14:79-86.
65. Wahrle S.E., Jiang H., Parsadanian M., Kim J., Li A., Knoten A., Jain S., Hirsch-Reinshagen V., Wellington C.L., Bales K.R., Paul S.M., Holtzman D.M. Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease. J.Clin. Invest. 2008, 118:671-682.
66. Walker D.W., Muffat J., Rundel C., Benzer S. Overexpression of a Drosophila homolog of apolipoprotein D leads to increased stress resistance and extended lifespan. Curr. Biol. 2006, 16:674-679.
67. Wang J., Tanila H., Puolivali J., Kadish I., van Groen T. Gender differences in the amount and deposition of amyloid beta in APPswe and PS1 double transgenic mice. Neurobiol. Dis. 2003, 14:318-327.
68. Yamamoto M., Kiyota T., Horiba M., Buescher J.L., Walsh S.M., Gendelman H.E., Ikezu T. Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice. Am. J. Pathol. 2007, 170:680-692.
69. Yan P., Bero A.W., Cirrito J.R., Xiao Q., Hu X., Wang Y., Gonzales E., Holtzman D.M., Lee J.M. Characterizing the appearance and growth of amyloid plaques in APP/PS1 mice. J.Neurosci. 2009, 29:10706-10714.